Page last updated: 2024-08-24

5-methylcytosine and Minimal Disease, Residual

5-methylcytosine has been researched along with Minimal Disease, Residual in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdel-Wahab, O; Fantin, V; Godley, LA; Kohrt, HE; Levine, R; Medeiros, BC; Pollyea, DA; Schenkein, D; Straley, K; Vasanthakumar, A; Zehnder, J; Zhang, B	1

Other Studies

1 other study(ies) available for 5-methylcytosine and Minimal Disease, Residual

Article	Year
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels. Leukemia & lymphoma, 2013, Volume: 54, Issue:2 Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Female; Glutarates; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Mutation; Neoplasm, Residual; Prognosis; Remission Induction; Treatment Outcome	2013

Article

Year

2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.

Leukemia & lymphoma, 2013, Volume: 54, Issue:2

Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Female; Glutarates; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Mutation; Neoplasm, Residual; Prognosis; Remission Induction; Treatment Outcome

2013